Anthropic Acquires Coefficient Bio for $400 Million to Build Drug Discovery Agents
Anthropic paid $400 million in stock for a stealth biotech startup with fewer than 10 employees, all former Genentech researchers. The team joins Anthropic's healthcare and life sciences division to build AI agents for drug discovery, clinical trial planning, and regulatory documentation. The acquisition comes the same week Anthropic cut off third-party agent platforms from Claude subscriptions.